About Cagent Vascular
Cagent Vascular is a company based in Wayne (United States) founded in 2014 by Robert Giasolli.. Cagent Vascular has raised $69.42 million across 6 funding rounds from investors including Trinity Capital, USVP and unknown. Cagent Vascular offers products and services including Serranator and Serranator SL-PRO. Cagent Vascular operates in a competitive market with competitors including Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others.
- Headquarter Wayne, United States
- Founders Robert Giasolli
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$69.42 M (USD)
in 6 rounds
-
Latest Funding Round
$15 M (USD), Series C
Feb 20, 2025
-
Investors
Trinity Capital
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cagent Vascular
Cagent Vascular offers a comprehensive portfolio of products and services, including Serranator and Serranator SL-PRO. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Balloon for predictable lumen gain in cardiovascular treatments.
Advanced balloon for effective treatment of various lesion morphologies.
Unlock access to complete
Funding Insights of Cagent Vascular
Cagent Vascular has successfully raised a total of $69.42M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $15 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $15.0M
-
First Round
First Round
(23 Jun 2014)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series C - Cagent Vascular | Valuation |
investors |
|
| Jan, 2024 | Amount | Series C - Cagent Vascular | Valuation | USVP | |
| Jun, 2021 | Amount | Series B - Cagent Vascular | Valuation | Sectoral |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cagent Vascular
Cagent Vascular has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Trinity Capital, USVP and unknown. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC firm that focuses on early stage investments in the US
|
Founded Year | Domain | Location | |
|
Sectoral Asset Management is focused on global healthcare investment.
|
Founded Year | Domain | Location | |
|
US seed and early-stage startups are funded by Synergy Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cagent Vascular
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cagent Vascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cagent Vascular Comparisons
Competitors of Cagent Vascular
Cagent Vascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avinger, Pathway Medical Technologies, Intact Vascular, LeMaitre Vascular and Okami Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of image-guided catheter-based products for peripheral artery disease
|
|
| domain | founded_year | HQ Location |
Smart devices are provided to clear peripheral arterial blockages.
|
|
| domain | founded_year | HQ Location |
Implants for repairing arteries after angioplasty are developed.
|
|
| domain | founded_year | HQ Location |
Devices for peripheral vascular disease treatment are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Innovative medical devices for peripheral vessel treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cagent Vascular
Frequently Asked Questions about Cagent Vascular
When was Cagent Vascular founded?
Cagent Vascular was founded in 2014.
Where is Cagent Vascular located?
Cagent Vascular is headquartered in Wayne, United States.
Is Cagent Vascular a funded company?
Cagent Vascular is a funded company, having raised a total of $69.42M across 6 funding rounds to date. The company's 1st funding round was a Series B of $9.5M, raised on Jun 23, 2014.
What does Cagent Vascular do?
Cagent Vascular was founded in 2014 in Wayne, United States, and operates in the medical device sector. Focus is placed on the development of a Lesion Preparation balloon, which aids in the effective removal of blockages in blood vessels and enhances drug uptake when combined with drug-coated balloons. Applications target the treatment of peripheral arterial disease, with ongoing efforts in vascular intervention technologies.
Who are the top competitors of Cagent Vascular?
Cagent Vascular's top competitors include Avinger, Okami Medical and LeMaitre Vascular.
What products or services does Cagent Vascular offer?
Cagent Vascular offers Serranator and Serranator SL-PRO.
Who are Cagent Vascular's investors?
Cagent Vascular has 6 investors. Key investors include Trinity Capital, USVP, unknown, Sectoral Asset Management, and Synergy Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.